Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Lilly and Incyte receive marketing approval for RA treatment Olumiant in Japan

pharmaceutical-technologyJuly 06, 2017

Tag: Lilly , Incyte , RA treatment Olumiant

PharmaSources Customer Service